C2C Wealth Management »

Novabay Pharmaceuticals shares owned by C2C Wealth Management

Quarter-by-quarter ownership of Novabay Pharmaceuticals (NBY) shares owned by C2C Wealth Management from 13F filings

Historical chart of C2C Wealth Management investment in Novabay Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Novabay Pharmaceuticals held by C2C Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Novabay Pharmaceuticals by C2C Wealth Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $254k 45k 5.64
2025-06-30 $57k 98k 0.58
2025-03-31 $32k 55k 0.59
2024-12-31 $31k 51k 0.60
2024-09-30 $31k 43k 0.72

More positions owned by C2C Wealth Management

Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corporation (MSFT)
Select Sector Spdr Tr State Street Tec (XLK)
Cohen & Steers infrastucture Fund (UTF)
International Business Machines (IBM)
Chevron Corporation (CVX)
Ishares Tr Russell 2000 Etf (IWM)
Eaton Vance Tax Managed Diversified Eq. (ETY)
Ishares Tr Core S&p Mcp Etf (IJH)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Core Us Aggbd Et (AGG)
Enterprise Products Partners (EPD)
Ishares Tr S&p Mc 400gr Etf (IJK)
Ishares Tr S&p Mc 400vl Etf (IJJ)

View all positions for C2C Wealth Management

Top funds holding Novabay Pharmaceuticals

Vanguard Group
Geode Capital Management
C2C Wealth Management
State Street Corporation
Apollon Wealth Management
Ground Swell Capital
Virtu Financial
Tower Research Capital
NVWM
Addison Advisors
Northwestern Mutual Wealth Management Company
Royal Bank of Canada

View all funds holding Novabay Pharmaceuticals